Efficacy and Safety of Two Immunosuppressive Regimens Mycophenolate Sodium (EC-MPS) With Short-term Steroid Use or Free of Steroids Compared With a Regimen of EC-MPS With Standard Steroids in de Novo Kidney Recipients.
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Mycophenolate sodium (Primary) ; Steroids
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Novartis
- 28 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jan 2011 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
- 28 Jan 2011 Actual initiation date changed from Feb 2004 to Mar 2004 as reported by ClinicalTrials.gov.